sentences:  In November 2017, several partners of KPMG, CMED's auditor from 2003 to 2008, faced contempt proceedings in Hong Kong High Court with regard to KPMG's refusal honor a February 2016 court order to produce Chinese working papers to the liquidators.The company is a Cayman Islands corporation, incorporated in 2004, based in China that purported to develop, manufacture and market advanced in vitro diagnostic ("IVD") products using enhanced chemiluminescence ("ECLIA") technology, fluorescent in-situ hybridization ("FISH") technology, and surface plasmon resonance (“SPR”) technology to detect and monitor various diseases and disorders.The ECLIA business purported to consist of ECLIA analyzer and reagent kits, as an IVD system based on ECLIA technology.